AdvaMed® Submits Comments on Genetic Testing in Oncology LCD
AdvaMed® submitted a letter to Medicare Administrative Contractors, Novitas and First Coast Service Options, regarding proposed LCDs on Genetic Testing in Oncology.
Diagnostics
Learn more about our Diagnostics work.
AdvaMedDx® COVID Testing Supply Retrospective Report
This report examines cumulative data from the first two years of the COVID Test Registry to demonstrate the mobilization of the diagnostics industry over the course of the pandemic.
The VALID Act Sponsor Prepared Summaries And Fact Sheets
Read a section-by-section breakdown of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021.
AdvaMed® Welcomes the UK Government’s Commitment to Address Elective Recovery and Access to Care
The Advanced Medical Technology Association® (AdvaMed®), working in the United Kingdom with the Medical Technology Group (MTG) and the Association of British HealthTech Industries (ABHI), commends the recent announcement by the UK Government of aggressive polices to address…
AdvaMed® Statement on White House Request for Information on COVID-19 Test Manufacturing
Today, AdvaMed® President and CEO Scott Whitaker applauded the White House’s Request for Information on policies to sustain diagnostic test manufacturing for COVID-19.
AdvaMed®, Semiconductor Industry Association Convene Roundtable on Supply Chain Issues
Last week, AdvaMed® President and CEO Scott Whitaker and Semiconductor Industry Association (SIA) President and CEO John Neuffer hosted a joint roundtable discussion that included dozens of industry leaders and…
AdvaMedDx® 2022 Priorities
AdvaMed® and AdvaMedDx® have prioritized supporting Medtech’s mobilization to the pandemic to protect patients and public health.
Canadian Hospital Specialties Limited Joins AdvaMed®, the World’s Leading Medical Technology Trade Association
February 9, 2022 — Canadian Hospital Specialties Limited (CHS) announced today that it has joined the Advanced Medical Technology Association® (AdvaMed®), the world’s leading trade association representing more than 400…
Medtech Poised to Make Significant Contribution to White House Cancer Moonshot
Chairman and CEO of Edwards Lifesciences, Mike Mussallem joins AdvaMed®’s Scott Whitaker to discuss the dedication of those in the industry and how policy reform can help speed up the…